Docoh
Loading...

BCDA BioCardia

News

From Benzinga Pro
BioCardia Q3 EPS $(0.16) Beats $(0.21) Estimate, Sales $821.00K Beat $10.00K Estimate
10 Nov 21
Earnings, News
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.21) by 23.81 percent. This is a 46.67 percent increase over losses of $(0.30) per share from the
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
10 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 10, 2021
10 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
BioCardia Reports New US Patent For Technology To Enhance Control For Interventional Catheter Based Therapies
12 Oct 21
News, Legal
BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of U.S. Patent
BioCardia Announces First Cross-Over Patient Treated In CardiAMP Cell Therapy Heart Failure Trial
7 Oct 21
Biotech, News, FDA, General
BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the treatment of the first
50 Biggest Movers From Yesterday
23 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Why BioCardia's Stock Is Trading Higher Today
22 Sep 21
News
BioCardia, Inc. (NASDAQ:BCDA) shares are trading higher after Roumell Asset Management reported in a 13D filing a 5.6% stake in the company.
32 Stocks Moving In Wednesday's Mid-Day Session
22 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
1 Sep 21
Pre-Market Outlook, Markets, Movers

Press releases

From Benzinga Pro
BioCardia Reports Third Quarter 2021 Financial Results and Business Highlights
10 Nov 21
Earnings, Press Releases
SAN CARLOS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported
BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021
8 Nov 21
News, Press Releases
SAN CARLOS, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
21 Oct 21
Press Releases
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary
BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial
7 Oct 21
Press Releases
SAN CARLOS, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary
BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)
9 Sep 21
News, Management, Press Releases
SAN CARLOS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), today announced it has recorded a company presentation that will be available on demand at the H.C. Wainwright 23rd Annual